In this interview, Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), discusses his background and experience in HEOR to help guide the audience to a better understanding of important considerations when using real-world evidence studies. He also covers how the work of HEOR professionals at Ingress and Cytel have been impacted by COVID-19. Other important HEOR topics such as market access studies and real-world analytics (RWA) for regulatory submission are covered as well. Read the full interview here.
(Source: Cytel Blog, 10/20/20)